ANTX — AN2 Therapeutics Inc

Stock analysis, AI verdict, fundamentals & technical signals

Rating: NEUTRAL

Price: $4.53 Analyst target: $9.00 Upside: 98.68%

About AN2 Therapeutics Inc

Anthem, Inc., is a health benefits company in the United States. The company is headquartered in Indianapolis, Indiana.

See the full interactive analysis & chart →

Informational only — not investment advice.